Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Seroprevalence of Immunoglobulin M and G Antibodies Against Sars-Cov-2 Virus: A Systematic Review and Meta-Analysis Study Publisher Pubmed



Vakili K1 ; Sayehmiri F2 ; Mohamadkhani A3 ; Ghanbari R3 ; Hajiesmaeili M4 ; Rezaeitavirani M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student research committee, Faculty of Medicine, Iran
  2. 2. Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Iran
  3. 3. Digestive Disease Research Center, Tehran University of Medical Sciences, Iran
  4. 4. Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, P.O. Box: 13336-35445, Tehran, Iran
  5. 5. Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Immunology Published:2021


Abstract

Background: Coronavirus disease 2019(COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new global health threat. Objectives: To analyze the effectiveness of the measurement of specific antibodies to SARS-CoV2 (IgM and IgG) for the diagnosis of COVID-19 and to analyze the rate of SARS-CoV2 seroprevalence in the population. Methods: 11 relevant studies, published before June 5, 2020, were included in this meta-analysis. These studies were identified by searching the MEDLINE and Scopus databases. The final selected studies were analyzed using STATA version 14. Publication bias was examined using both Egger’s test and Funnel plots. Moreover, the I2 statistic has been used to evaluate and verify heterogeneity. Results: The 11 relevant studies selected for the present metaanalysis cover a total of996 infection cases. According to the results, the average rate of positive cases for IgM (AU/mL) was 2.10 (95% CI: 1.65-2.55; I2=92.2%), and the sensitivity in individuals with positive IgM test was 63 (95% CI: 47-79; I2=94.9%). In addition, the average rate of positive cases for IgG (AU/mL) was 67.44 (95% CI: 28.79-106.09; I2=99.4%), and the sensitivity in individuals with positive IgG test was 79 (95% CI: 67-90; I2=89.5%). Conclusions: According to this analysis, detection of anti-SARS- CoV-2 IgM and IgG antibodies may assist early detection of SARS- CoV2 infection. Whether antibodies against SARS-CoV-2 confer protective immunity warrants further studies. © 2021, Shiraz University of Medical Sciences. All rights reserved.
Other Related Docs
14. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
17. Being a Front-Line Dentist During the Covid-19 Pandemic: A Literature Review, Maxillofacial Plastic and Reconstructive Surgery (2020)
20. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
21. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
33. Precision Medicine in Infectious Disease, Precision Medicine in Clinical Practice (2022)
34. Green Chemistry and Coronavirus, Sustainable Chemistry and Pharmacy (2021)
40. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
41. Transmission Modes of Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2021)
42. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)